Skip to content

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

SKYE Skye Bioscience, Inc. Common Stock
$1.54 4.11% +0.06
Notify me if price changes either direction
Interactive Brokers Logotype

Buy SKYE stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades
Loading

Key Stats

Market cap. 45.2M
Enterprise value 11.8M
Trailing PE 3.566038
Forward PE -1.2586207
PEG Ratio 0.029716983333333
Enterprise to EBITDA -0.222
Price to book MRQ 1.3773586

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter (MRQ) 2025-06-30
EBITDA -53216884
Diluted EPS TTM -1.06
Total Cash (MRQ) 35.3M
Current ratio (MRQ) 4.771
Operating Cash Flow (TTM) -41469144

SKYE trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent SKYE News

Trade, Swap & Stake Crypto on Uphold

Buy, sell, and swap crypto. Stake crypto, earn rewards and securely manage 300+ assets—all in one trusted platform. Terms apply. Capital at risk.

Get Started

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.